PARIS] Ozempic-maker Novo Nordisk is planning to make more of its medicines for the US market in the country; Boeing risks a gummed up supply chain and higher aircraft costs it may not be able to pass ...
Investors, financial advisors Tracking the stock market with new tariffs being implemented and ongoing trade disputes with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback